CClinicalTrials.gg
Not yet recruitingNCT06039215PARAVENTUpdated Sep 15, 2023

Paramedical Protocol for Ventilation in Acute Respiratory Distress Syndrome

An interventional study of Ventilatory adjustments by nurses in Acute Respiratory Distress Syndrome, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-15.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
540
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Acute respiratory distress syndrome (ARDS) is a frequent pathology in intensive care (around 10% of patients admitted to intensive care and almost a quarter of patients on mechanical ventilation) and a serious one, with a hospital mortality rate of 40%. The main measures that have an effect on mortality in ARDS involve adjustments to the ventilator, known as protective ventilation. In the most severe patients, adjuvant measures such as prone positioning and the use of curarisation in the initial phase of the disease can improve survival. All these measures have been included in the latest national and international recommendations. However, a vast observational study carried out in 50 countries revealed low compliance with these recommendations. More than a third of patients did not receive protective ventilation, and the majority did not receive prone positioning when this was indicated. During weaning from artificial ventilation, it has been widely demonstrated that replacing clinician judgement with the implementation of paramedical care protocols improved weaning and significantly reduced the duration of artificial ventilation. Therefore, investigators hypothesize that the implementation of a paramedical care protocol for ventilation in the acute phase of ARDS improves compliance with recommendations and thus reduces mortality and the duration of artificial ventilation. However, implementation of such a protocol requires operational training for all the nurses in the participating departments. Simulation appears to be the training method of choice, as it is a teaching technique that enables technical and non-technical skills to be passed on with good retention of what has been learnt, as well as assessing what has been learnt. To make it possible to train several dozen nurses within a tight timescale, a partially dematerialized simulation model incorporating innovative e-learning tools will be developed.

02

Conditions studied

  • Acute Respiratory Distress Syndrome

Keywords

  • Acute respiratory distress syndrome
  • ARDS
  • Paramedical care protocol
  • Mortality
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's planned enrollment of 540 is above the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18 years
  • Intensive care hospitalization;
  • Intubation with artificial ventilation;
  • ARDS evolving for less than 72 hours. ARDS criteria according to the Berlin definition, as follows:

    • Exposure to a risk factor for ARDS or onset/aggravation of pulmonary symptoms within the previous 7 days ;
    • Respiratory distress not fully explained by cardiac failure or volume overload, with exclusion of hydrostatic edema in the absence of exposure to a risk factor for ARDS;
    • Hypoxemia with PaO2/FiO2 ratio \< 300 mm Hg under PEEP ≥ 5 cmH2O ;
    • Bilateral opacities on chest X-ray, lung ultrasound or chest CT, not fully explained by pleural effusions, atelectasis or nodules.
  • Blood pressure monitoring
  • Affiliation to the social security system.
  • Written informed consent (patient, relative) or inclusion in emergency situation.

Exclusion criteria

Exclusion Criteria:

  • Long-term oxygen therapy;
  • Pneumothorax or drained pleurisy;
  • Documented pulmonary embolism;
  • Intracranial hypertension;
  • ARDS refractory to inclusion, i.e.: i) oxygen partial pressure on inspired oxygen fraction a ratio (PaO2/FiO2) \<80 mm Hg or plateau pressure (Pplat) > 32 cmH2O despite optimization of mechanical ventilation (tidal volume (Vt) set at 6 mL/kg weight predicted by height, FiO2 ≥80% and positive expiratory pressure (PEEP) ≥10 cmH2O) and despite the use of complementary therapies (including prone and/or inhaled nitric oxide); or ii) pH \<7. 25 with PaCO2 ≥60 mm Hg;
  • ARDS evolving for more than 72 hours with intubation and mechanical ventilation;
  • Patient deprived of liberty;
  • Patient under legal protection (guardianship or curatorship);
  • Known pregnancy or breast-feeding (a pregnancy test will be performed prior to inclusion in patients of childbearing age).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
540 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.

    Other: Ventilatory adjustments by nurses

  • No intervention
    Control group

    The ventilator settings are adjusted in line with the centre's usual practice. No change from usual management of acute respiratory distress syndrome.

Interventions

  • OtherVentilatory adjustments by nurses

    Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.

    Also known as: Post-intervention period

06

What researchers measure

Primary outcomes

  1. Mortality rate and number of days without mechanical ventilation

    The primary endpoint will be a combination of mortality and the number of days without mechanical ventilation at D28. This composite criterion will be prioritised so that survival is given priority in the analysis over the shorter duration of mechanical ventilation.

    Time frame: 28 days

Secondary outcomes

  1. Mesure of tidal volume ventilation

    Time frame: Up to Day 7

  2. Mesure of plateau pressure

    Time frame: Up to Day 7

  3. Mesure of positive end-expiratory pressure (PEEP)

    Time frame: Up to Day 7

  4. Mesure of FiO2

    Time frame: Up to Day 7

  5. Oxygenation

    arterial blood gases and SpO2

    Time frame: Up to Day 7

  6. Number of days without mechanical ventilation

    Time frame: Up to Day 28

  7. Number of days without catecholamine

    Time frame: Up to Day 28

  8. Number of days without continuous sedation

    Time frame: Up to Day 28

  9. Duration of mechanical ventilation .

    from intubation to successful extubation

    Time frame: Up to Day 28

  10. Occurrence of mechanically ventilated pneumothorax

    Time frame: Up to Day 28

  11. Duration of Acute respiratory distress syndrome

    defined as the day on which the 1st test of spontaneous ventilation was performed

    Time frame: UP to Day 28

  12. Duration of weaning from mechanical ventilation

    measured as the time between the 1st test of spontaneous ventilation and successful extubation (patient alive and without reintubation within 7 days of extubation).

    Time frame: Up to Day 28

  13. Number of participants with rescue therapy

    Time frame: Up to Day 28

  14. Rate of re-intubation

    Time frame: Up to Day 28

  15. Rate of use of non-invasive ventilation and curative high-flow oxygen therapy

    Time frame: Up to Day 28

  16. Tracheostomy rate

    Time frame: Up to Day 28

  17. Length of stay in intensive care and in hospital.

    Time frame: Up to day 28

  18. Number of deaths in ICU and hospital

    Time frame: Up to Day 28

  19. Number of nurses trained in paramedical protocol per center.

    Time frame: Up to 26 months

07

Study locations

1 site
  • Assistance Publique-Hôpitaux de Paris service de santé publique
    Créteil, Creteil 94010, France
    • Assistance Publique-Hôpitaux de Paris service de santé publique · Contact · samia.baloul@aphp.fr · 0145178638
08

References and documents

Individual participant data

Plan to share: No — DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06039215
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Sep 15, 2023
Start date
Oct 1, 2023 (estimated)
Primary completion
Aug 1, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
Sep 15, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion